High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy
Lionel Couzi(Centre National de la Recherche Scientifique), Pierre Merville(Centre National de la Recherche Scientifique), Thomas Bachelet, S. Helou(Hôpital Pellegrin), Séverine Martin(Hôpital Pellegrin), Karine Moreau(Centre Hospitalier Universitaire de Bordeaux), Sophie Alain(Université de Limoges), Isabelle Garrigue(Centre National de la Recherche Scientifique), Bernard Boyer(Centre Hospitalier Universitaire de Limoges), D. Morel(Centre Hospitalier Universitaire de Bordeaux), Marie‐Edith Lafon
Cited by 92
Related Papers
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
|The Lancet Infectious Diseases|2017|822
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
|Immunity|2015|223
Bacterial Populations Contaminating The Upper Gut in Patients With Small Intestinal Bacterial Overgrowth Syndrome
|The American Journal of Gastroenterology|1999|196
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study
|Clinical Journal of the American Society of Nephrology|2016|192